<?xml version="1.0" encoding="UTF-8"?>
<p>Preclinical data suggested that andrographolide could be responsible of pharmacokinetics interactions, as it induced CYP1A2 [
 <xref rid="B219-vaccines-08-00468" ref-type="bibr">219</xref>]. The European Medicines Agency (EMA) reports a possibility of causing reproductive toxicity of Andrographis extracts (decreases in sperm motility and counts) [
 <xref rid="B219-vaccines-08-00468" ref-type="bibr">219</xref>]. On the other hand, no major adverse effects have been reported for 
 <italic>A. paniculata</italic>; only minor side effects, mainly gastrointestinal, are known [
 <xref rid="B219-vaccines-08-00468" ref-type="bibr">219</xref>]. 
</p>
